Shipbuilders’ group warns US failing to tap full naval industry capacity
Wasp-class amphibious assault ship USS Bataan prepares for a dead-stick underway. (Photo: US Navy)
The Amphibious Warship Industrial Base Coalition has pointed out that issues related to bureaucracy, prerequisites and predictability have been limiting the involvement of smaller shipyards in military acquisition programmes in the US.
The US may not be fully utilising its current shipbuilding capacity, despite the pressing concern to keep pace with Chinese naval advancements. Difficult-to-attain requirements, low levels of predictability and bureaucracy have been cited by the Amphibious Warship Industrial Base Coalition (AWIBC) as issues preventing small and medium suppliers from participating in US Navy (USN), Marine Corps (USMC), and Coast Guard (USCG) programmes.
Relying on a few traditional shipyards for decades has resulted in multiple postponements of milestones of acquisition effort in addition to over costs, the coalition said.
Speaking to Shephard, AWIBC chair Paul J. Roden explained that
Already have an account? Log in
Want to keep reading this article?
More from Naval Warfare
-
![Royal Canadian Navy’s SEA Torpedo Launcher Systems to enter production in Ottawa in November]()
Royal Canadian Navy’s SEA Torpedo Launcher Systems to enter production in Ottawa in November
The article acceptance testing for the TLS is scheduled for the end of 2026.
-
![Netherlands to acquire Finnish littoral assault craft in LCVP replacement programme]()
Netherlands to acquire Finnish littoral assault craft in LCVP replacement programme
The Dutch navy had reportedly been considering BAE Systems’ Littoral Strike Craft to replace its ageing landing craft fleet.
-
![Swedish navy moves to final phase of Blekinge-class sub production with new Saab order]()
Swedish navy moves to final phase of Blekinge-class sub production with new Saab order
Saab Kockums was initially awarded the contract to build two A26 submarines for the Royal Swedish Navy in 2015, but the programme has faced delays and escalating costs.
